Medivation

📍 New York, United States🗓 Founded 2004👥 108 employees💰 Last funded Feb 2013
Pharmaceutical Manufacturing🌐 medivation.com
Website LinkedIn
Medivation Inc., which is now a part of Pfizer, Inc. is focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation’s goal is to transform the treatment of these diseases and offer hope to critically ill patients and their families. With the approval of Xtandi (enzalutamide) capsules in late August 2012 and the product launch immediately following, Medivation is continuing to build and develop a world-class workforce to take the company to the next strategic level. Medivation was founded in 2004 by a group of experienced professionals with a long track record of working together successfully as a team in the pharmaceutical and biotechnology industries. They founded Medivation to leverage that expertise to bridge the medical product development gap between early-stage development and product launch. Medivation currently has 500+ employees located in beautiful downtown San Francisco, CA. For additional company information, please visit our website at www.medivation.com.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2004
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Medivation?
Medivation has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Medivation last raise funding?
The most recent investment in Medivation recorded on gritt.io was in February 2013.
When was Medivation founded?
Medivation was founded in 2004.
What industry is Medivation in?
Medivation operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Medivation based?
Medivation is headquartered in New York, United States.